Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial damage refers to injury or dysfunction in the endothelium—the thin layer of cells lining the interior surface of blood vessels. The endothelium plays critical roles in regulating vascular tone through nitric oxide production, controlling permeability between blood and tissues, modulating inflammation and thrombosis, and maintaining overall cardiovascular health. Damage to this layer impairs these functions and leads to increased risk for vasoconstriction, inflammation, thrombosis (blood clotting), hypertension, and progression toward diseases such as atherosclerosis. Common biomarkers indicating endothelial injury include reduced nitric oxide levels and elevated markers like CRP or D-dimer. While many therapies aim to protect or restore healthy endothelial function by targeting underlying causes such as oxidative stress or high cholesterol with antioxidants or statins respectively, "endothelial damage" itself is not considered a discrete therapeutic target like an enzyme or receptor but rather describes an adverse pathological condition that underlies many cardiovascular diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial damage.